Evaluating Veracyte's Medium And Long-Term Prospects [Seeking Alpha]
Veracyte, Inc. (VCYT)
Last veracyte, inc. earnings: 2/25 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.veracyte.com/investor-relations
Company Research
Source: Seeking Alpha
Veracyte ( VCYT ) is a diagnostics company that combines machine learning with gene sequencing to facilitate the diagnostic process. VCYT currently offers three products: Afirma, Percepta and Envisia. Afirma has been on the market since 2011; in contrast, Percepta and Envisia are both (relatively) new products. Percepta has been commercially available for a year while Envisia is going commercial in 2019. VCYT has had a good run in recent quarters, going from $6.60 at the beginning of the year to $12.50 at the time of writing. VCYT data by YCharts This is largely due to the high level of growth that they have been delivering over the past year. 1 1 Click to enlarge Notes: Source: November 2018 Canaccord Presentation With a market cap around $500M, VCYT may still have room to grow as it tries to break-even within the next few years. Afirma - A raising standard in thyroid nodule diagnostics: Afirma is being
Show less
Read more
Impact Snapshot
Event Time:
VCYT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VCYT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VCYT alerts
High impacting Veracyte, Inc. news events
Weekly update
A roundup of the hottest topics
VCYT
News
- Is Veracyte, Inc. (NASDAQ:VCYT) Trading At A 43% Discount? [Yahoo! Finance]Yahoo! Finance
- Veracyte, Inc. (NASDAQ:VCYT) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Veracyte (VCYT) Reports Narrower Q1 Loss, Raises '24 Sales View [Yahoo! Finance]Yahoo! Finance
- Veracyte, Inc. (NASDAQ: VCYT) had its price target lowered by analysts at Needham & Company LLC from $33.00 to $27.00. They now have a "buy" rating on the stock.MarketBeat
- Veracyte Announces First Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
VCYT
Earnings
- 5/7/24 - Beat
VCYT
Sec Filings
- 5/8/24 - Form 10-Q
- 5/7/24 - Form 8-K
- 4/25/24 - Form ARS
- VCYT's page on the SEC website